<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">CMV </span>
   <span class="font22">letermovir </span>
   <span class="font20">DNA </span>
   <span class="font19">viral </span>
   <span class="font18">cytomegalovirus </span>
   <span class="font18">terminase </span>
   <span class="font18">human </span>
   <span class="font17">pUL </span>
   <span class="font17">transplant </span>
   <span class="font16">antiviral </span>
   <span class="font16">treatment </span>
   <span class="font15">clinical </span>
   <span class="font15">complex </span>
   <span class="font15">drug </span>
   <span class="font15">{border-style </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">disease </span>
   <span class="font14">Phase </span>
   <span class="font14">drugs </span>
   <span class="font14">novel </span>
   <span class="font13">infection </span>
   <span class="font13">resistance </span>
   <span class="font13">Letermovir </span>
   <span class="font13">activity </span>
   <span class="font13">compared </span>
   <span class="font13">use </span>
   <span class="font13">studies </span>
   <span class="font12">currently </span>
   <span class="font12">solid </span>
   <span class="font12">Virol </span>
   <span class="font12">effects </span>
   <span class="font12">mechanism </span>
   <span class="font12">organ </span>
   <span class="font12">pUL, </span>
   <span class="font12">patients </span>
   <span class="font12">potential </span>
   <span class="font12">prophylaxis </span>
   <span class="font12">protein </span>
   <span class="font12">significant </span>
   <span class="font12">vitro </span>
   <span class="font12">CMV, </span>
   <span class="font12">HSCT </span>
   <span class="font12">active </span>
   <span class="font12">adverse </span>
   <span class="font12">daily </span>
   <span class="font12">doses </span>
   <span class="font12">prevention </span>
   <span class="font12">process </span>
   <span class="font12">proteins </span>
   <span class="font12">recipients </span>
   <span class="font12">study </span>
   <span class="font12">Drug </span>
   <span class="font12">action </span>
   <span class="font12">benzimidazole </span>
   <span class="font12">highly </span>
   <span class="font12">letermovir, </span>
   <span class="font12">levels </span>
   <span class="font12">mutations </span>
   <span class="font12">placebo </span>
   <span class="font12">px; </span>
   <span class="font12">recipients. </span>
   <span class="font12">replication </span>
   <span class="font12">strains </span>
   <span class="font12">subunit </span>
   <span class="font12">termination </span>
   <span class="font12">translocation </span>
   <span class="font12">trial </span>
   <span class="font12">{font-family </span>
   <span class="font11">GCV </span>
   <span class="font11">GCV, </span>
   <span class="font11">approved </span>
   <span class="font11">common </span>
   <span class="font11">font-size </span>
   <span class="font11">gene </span>
   <span class="font11">high </span>
   <span class="font11">kidney </span>
   <span class="font11">multidrug-resistant </span>
   <span class="font11">portal </span>
   <span class="font11">received </span>
   <span class="font11">serum </span>
   <span class="font11">specific </span>
   <span class="font11">BDCRB </span>
   <span class="font11">CMV. </span>
   <span class="font11">Infect </span>
   <span class="font11">Transplant </span>
   <span class="font11">appears </span>
   <span class="font11">associated </span>
   <span class="font11">capsid </span>
   <span class="font11">cell </span>
   <span class="font11">compound </span>
   <span class="font11">developed </span>
   <span class="font11">different </span>
   <span class="font11">dose </span>
   <span class="font11">double; </span>
   <span class="font11">functional </span>
   <span class="font11">group </span>
   <span class="font11">herpesviruses </span>
   <span class="font11">interaction </span>
   <span class="font11">lower </span>
   <span class="font11">nuclear </span>
   <span class="font11">reported </span>
   <span class="font11">results </span>
   <span class="font11">safety </span>
   <span class="font11">stem </span>
   <span class="font11">structure </span>
   <span class="font11">trials </span>
   <span class="font11">unique </span>
   <span class="font11">(which </span>
   <span class="font11">Agents </span>
   <span class="font11">CDV, </span>
   <span class="font11">Dis </span>
   <span class="font11">However, </span>
   <span class="font11">UL, </span>
   <span class="font11">allogeneic </span>
   <span class="font11">anti-CMV </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cleavage </span>
   <span class="font11">data </span>
   <span class="font11">day </span>
   <span class="font11">does </span>
   <span class="font11">drugs. </span>
   <span class="font11">effect </span>
   <span class="font11">encoded </span>
   <span class="font11">exhibit </span>
   <span class="font11">genome </span>
   <span class="font11">healthy </span>
   <span class="font11">importin </span>
   <span class="font11">inhibitor </span>
   <span class="font11">inhibitors </span>
   <span class="font11">interacts </span>
   <span class="font11">load </span>
   <span class="font11">low </span>
   <span class="font11">packaging </span>
   <span class="font11">patient </span>
   <span class="font11">profile </span>
   <span class="font11">promising </span>
   <span class="font11">protein), </span>
   <span class="font11">site </span>
   <span class="font11">solid; </span>
   <span class="font11">synthesis. </span>
   <span class="font11">using </span>
   <span class="font11">versus </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">BAY </span>
   <span class="font11">C-terminal </span>
   <span class="font11">Chemother </span>
   <span class="font11">Goldner </span>
   <span class="font11">Tmax </span>
   <span class="font11">antivirals </span>
   <span class="font11">bold </span>
   <span class="font11">bone </span>
   <span class="font11">complex. </span>
   <span class="font11">concentration </span>
   <span class="font11">courier; </span>
   <span class="font11">cross-resistance </span>
   <span class="font11">days </span>
   <span class="font11">development </span>
   <span class="font11">effective </span>
   <span class="font11">efficacy </span>
   <span class="font11">em; </span>
   <span class="font11">essential </span>
   <span class="font11">evaluated </span>
   <span class="font11">failure </span>
   <span class="font11">finding </span>
   <span class="font11">given </span>
   <span class="font11">groups </span>
   <span class="font11">hematopoietic </span>
   <span class="font11">immune </span>
   <span class="font11">inhibition </span>
   <span class="font11">inhibits </span>
   <span class="font11">interactions </span>
   <span class="font11">known </span>
   <span class="font11">letermovir. </span>
   <span class="font11">lung </span>
   <span class="font11">major </span>
   <span class="font11">management </span>
   <span class="font11">marrow </span>
   <span class="font11">maturation </span>
   <span class="font11">multiple </span>
   <span class="font11">nuclease </span>
   <span class="font11">open </span>
   <span class="font11">potent </span>
   <span class="font11">presented </span>
   <span class="font11">pt;} </span>
   <span class="font11">rate </span>
   <span class="font11">resistant </span>
   <span class="font11">risk </span>
   <span class="font11">sequence </span>
   <span class="font11">showed </span>
   <span class="font11">small </span>
   <span class="font11">standard </span>
   <span class="font11">subunits </span>
   <span class="font11">suggesting </span>
   <span class="font11">unit-length </span>
   <span class="font11">used </span>
   <span class="font11">vivo </span>
  </p>
 </body>
</html>
